BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16600504)

  • 1. Intragastric proteasome inhibition induces alpha-synuclein-immunopositive aggregations in neurons in the dorsal motor nucleus of the vagus in rats.
    Miwa H; Kubo T; Suzuki A; Kondo T
    Neurosci Lett; 2006 Jun; 401(1-2):146-9. PubMed ID: 16600504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.
    Chu Y; Dodiya H; Aebischer P; Olanow CW; Kordower JH
    Neurobiol Dis; 2009 Sep; 35(3):385-98. PubMed ID: 19505575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
    Lee FK; Wong AK; Lee YW; Wan OW; Chan HY; Chung KK
    J Neurochem; 2009 Jul; 110(1):208-19. PubMed ID: 19457126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic systemic pesticide exposure reproduces features of Parkinson's disease.
    Betarbet R; Sherer TB; MacKenzie G; Garcia-Osuna M; Panov AV; Greenamyre JT
    Nat Neurosci; 2000 Dec; 3(12):1301-6. PubMed ID: 11100151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology.
    Braak H; de Vos RA; Bohl J; Del Tredici K
    Neurosci Lett; 2006 Mar; 396(1):67-72. PubMed ID: 16330147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct synaptic contacts on the myenteric ganglia of the rat stomach from the dorsal motor nucleus of the vagus.
    Hayakawa T; Kuwahara S; Maeda S; Tanaka K; Seki M
    J Comp Neurol; 2006 Sep; 498(3):352-62. PubMed ID: 16871527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional effects and characteristics of cecum-projecting neurons in the dorsal motor nucleus of the vagus of rats.
    Cao X; Ball AJ; Partosoedarso ER; Burmeister MA; Hornby PJ
    Auton Neurosci; 2007 Jan; 131(1-2):1-8. PubMed ID: 16950660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally.
    Ling Z; Chang QA; Tong CW; Leurgans SE; Lipton JW; Carvey PM
    Exp Neurol; 2004 Dec; 190(2):373-83. PubMed ID: 15530876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galanin inhibits gut-related vagal neurons in rats.
    Tan Z; Fogel R; Jiang C; Zhang X
    J Neurophysiol; 2004 May; 91(5):2330-43. PubMed ID: 14695348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cells of origin of vagal motor neurons projecting to different parts of the stomach in the rat: confocal laser scanning and electron microscopic study.
    Hayakawa T; Takanaga A; Tanaka K; Maeda S; Seki M
    Anat Embryol (Berl); 2003 Dec; 207(4-5):289-97. PubMed ID: 14608504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of the 27-kDa heat shock protein (Hsp27) in the rat medulla oblongata after vagus nerve injury.
    Hopkins DA; Plumier JC; Currie RW
    Exp Neurol; 1998 Oct; 153(2):173-83. PubMed ID: 9784277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasomal inhibition induced by manganese ethylene-bis-dithiocarbamate: relevance to Parkinson's disease.
    Zhou Y; Shie FS; Piccardo P; Montine TJ; Zhang J
    Neuroscience; 2004; 128(2):281-91. PubMed ID: 15350641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution and ultrastructure of dopaminergic neurons in the dorsal motor nucleus of the vagus projecting to the stomach of the rat.
    Hayakawa T; Takanaga A; Tanaka K; Maeda S; Seki M
    Brain Res; 2004 Apr; 1006(1):66-73. PubMed ID: 15047025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys.
    Kordower JH; Kanaan NM; Chu Y; Suresh Babu R; Stansell J; Terpstra BT; Sortwell CE; Steece-Collier K; Collier TJ
    Ann Neurol; 2006 Aug; 60(2):264-8. PubMed ID: 16862579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pragmatic approach to biochemical systems theory applied to an alpha-synuclein-based model of Parkinson's disease.
    Sass MB; Lorenz AN; Green RL; Coleman RA
    J Neurosci Methods; 2009 Apr; 178(2):366-77. PubMed ID: 19136028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression.
    Maingay M; Romero-Ramos M; Carta M; Kirik D
    Neurobiol Dis; 2006 Sep; 23(3):522-32. PubMed ID: 16806952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease.
    Xie W; Li X; Li C; Zhu W; Jankovic J; Le W
    J Neurochem; 2010 Oct; 115(1):188-99. PubMed ID: 20649845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
    Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
    J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered Expression of D1 and D2 Dopamine Receptors in Vagal Neurons Innervating the Gastric Muscularis Externa in a Parkinson's Disease Rat Model.
    Wang ZY; Lian H; Zhou L; Zhang YM; Cai QQ; Zheng LF; Zhu JX
    J Parkinsons Dis; 2016 May; 6(2):317-23. PubMed ID: 27164043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-synuclein transgenic mice display age-related slowing of gastrointestinal motility associated with transgene expression in the vagal system.
    Noorian AR; Rha J; Annerino DM; Bernhard D; Taylor GM; Greene JG
    Neurobiol Dis; 2012 Oct; 48(1):9-19. PubMed ID: 22722052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.